Beijing's Changping unleashes high tech creativity

By Zhang Jiaqi
0 Comment(s)Print E-mail China.org.cn, February 14, 2022
Adjust font size:
A hydrogen-fueled bus developed and manufactured by SPIC, Feb. 11, 2022. Some 150 such buses are in use for the Winter Olympics in downtown Beijing and suburban Yanqing. [Photo by Zhang Jiaqi/China.org.cn]

While Beijing is presenting the world with a green Winter Olympics, hydrogen fuel is playing its part. Some 150 hydrogen-powered buses developed by the State Power Investment Corporation Limited (SPIC) are currently in use for the Games in downtown Beijing and suburban Yanqing.

Zhang Yinguang, general manager of SPIC Hydrogen Energy Co., Ltd., introduced the company's achievements during a visit to SPIC by 40 journalists from over two dozen Chinese and foreign media outlets. Located in the Future Science City in Beijing's northwestern Changping district, SPIC is just one of over 500 energy companies located here in the "energy valley."

In recent years, Changping district has seen continued growth in high tech creativity. Over the past decade, the Future Science City in the district has expanded from around 10 square kilometers to over 170 square kilometers, bringing together increasingly innovative market entities.

So far, the buses developed and manufactured by SPIC have performed well in terms of both technological reliability and service quality, boosting the industry's confidence in popularizing the use of hydrogen energy, said Zhang, adding that "the Winter Olympics will be of milestone significance to the development of hydrogen energy."

According to Fan Jihong, head of SPIC Research Institute, by the end of last year, SPIC's installed capacity of new energy was 79.36 million kilowatts, ranking first in the world.

Besides the energy companies, life science research institutes, labs and companies are also clustered in the Future Science City, forming a "life valley."

Beijing InnoCare Pharma is one of over 500 innovation-based companies in the "life valley," and its proprietary drug "orelabrutinib" was approved for marketing in China and included in the national reimbursement drug list last December, benefiting lymphoma patients.

According to Lu Chunhua, senior director of corporate communication at InnoCare, the company has submitted 224 patent applications and been granted 37 patent licenses in China and around the world since its inception in 2015.

"Innovation is always the foundation for the biotech industry, and we are happy to grow in Changping, which is a hotbed for innovation in Beijing," Lu said.

Follow China.org.cn on Twitter and Facebook to join the conversation.
ChinaNews App Download
Print E-mail Bookmark and Share

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:   
    Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileRSSNewsletter
主站蜘蛛池模板: 国产精品福利一区二区| 99久久无色码中文字幕人妻蜜柚| a毛片免费在线观看| 亚洲综合色一区二区三区小说| 亚洲国产欧美一区二区欧美 | 人妻少妇精品视频一区二区三区| 狠狠色噜噜狠狠狠狠69| 田中瞳中文字幕久久精品| 杨贵妃艳史毛片在线播放免费观看| 引诱亲女乱小说完整版18| 国产无遮挡裸体免费视频在线观看 | 亚洲国产第一页| 中文字幕日韩精品一区二区三区| 99re热这里只有精品| 草莓视频在线免费观看下载| 欧美精品videossex欧美性| 无套内射无矿码免费看黄| 国产精品一区二区久久国产| 午夜dj在线观看免费高清在线| 亚洲av无码一区二区三区性色| jlzz大全高潮多水老师| 野花日本免费观看高清电影8| 欧美日韩一区二区三区自拍| 小雄和三个护士阅读| 国产凌凌漆国语| 亚洲一区二区三区播放在线 | 国产日产久久高清欧美一区| 亚洲精品无码乱码成人| 中国老熟妇xxxxx| 高清国语自产拍免费视频国产| 欧美日韩高清在线| 女人是男人的未来1分29分| 国产一区二区精品| 久久综合综合久久综合| 2020国产在线| 窝窝视频成人影院午夜在线| 日韩精品一区二区三区老鸦窝 | 男女一边摸一边做爽视频| 欧美乱xxxxxxxxx| 国产精品模特hd在线| 亚洲国产日韩欧美|